Repligen Corporation Stock Intrinsic Value – Repligen Corporation Announces Second Quarter 2023 Results
🌥️Trending News Repligen Corporation ($NASDAQ:RGEN), headquartered in Waltham, Massachusetts, is a bioprocessing company dedicated to providing advanced technologies and products [...]
Repligen Corporation Intrinsic Stock Value – Zacks Research Downgrades Q2 2024 Earnings Estimates for Repligen Corporation
🌥️Trending News Repligen Corporation ($NASDAQ:RGEN) is a Massachusetts-based biopharmaceutical company specializing in therapeutic proteins and biologic drugs. Today, Zacks Research [...]
RGEN: Invest in a Rare Pure Bioprocessing Play with Impressive Growth Prospects
☀️Trending News Repligen Corporation ($NASDAQ:RGEN) (RGEN) is a biopharmaceutical company with a focus on bioprocessing, a fast-growing segment of the [...]
Repligen Corporation Unable to Replicate Strong Results
☀️Trending News Repligen Corporation ($NASDAQ:RGEN), a biotechnology company focused on providing innovative products and services to the life-sciences industry, has [...]
Russell Investments Group Ltd. Decreases Stake in Repligen Corporation
Trending News 🌥️ Repligen Corporation ($NASDAQ:RGEN) is a biopharmaceutical company that focuses on the development, production, and commercialization of drugs [...]
Repligen Corporation Reports Non-GAAP EPS of $0.64, Revenues of $182.66M, Beating Estimates by $0.05 and $1.23M Respectively
Trending News 🌧️ Repligen Corporation ($NASDAQ:RGEN), a bioprocessing and bioproducts company, recently reported its Non-GAAP earnings per share (EPS) of [...]
Repligen Corporation to Strengthen Portfolio with Acquisition of FlexBiosys
Trending News ☀️ Repligen Corporation ($NASDAQ:RGEN), an integrated bioprocessing partner to the biopharma industry, recently announced its plan to acquire [...]
Repligen Corporation Stock Drops 11.4% Following Recent Earnings Report
Trending News 🌥️ Repligen Corporation ($NASDAQ:RGEN) (RGEN) has experienced a significant drop in its stock price, falling 11.4% since its [...]
Pathstone Family Office LLC Increases Investment in Repligen Corporation in 2023.
Trending News 🌥️ In 2023, Pathstone Family Office LLC made a major investment in Repligen Corporation ($NASDAQ:RGEN), increasing their already [...]
REPLIGEN CORPORATION Reports Fourth Quarter FY2022 Earnings Results on February 22 2023.
Earnings report REPLIGEN CORPORATION ($NASDAQ:RGEN) reported their financial results for the fourth quarter of FY2022, which ended on December 31 [...]
